NCT06685159 Predictors of Postoperative Complications in Surgery With Pneumoperitoneum in the Trendelenburg Position
| NCT ID | NCT06685159 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Reuven Pizov |
| Condition | Trendelenburg Position |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-06-19 |
| Primary Completion | 2026-06-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-06-19 with a primary completion date of 2026-06-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluate early postoperative complications after surgery in Trendelenburg position with increased intraabdominal pressure (surgery with pneumoperitoneum). Evaluate the relationship between hemodynamic and metabolic changes on perioperative outcome.
Eligibility Criteria
Inclusion Criteria: * ASA Class I-IV. * Planned for laparoscopic surgery in the Trendelenburg position that is expected to last more than 2 hours. * Planned arterial catheter insertion. Exclusion Criteria: * Pregnancy. * Planned open abdominal surgery. * Renal Replacement Therapy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06685159 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Trendelenburg Position. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06685159 currently recruiting?
Yes, NCT06685159 is actively recruiting participants. Contact the research team at pizovr@hadassah.org.il for enrollment information.
Where is the NCT06685159 trial being conducted?
This trial is being conducted at Jerusalem, Israel.
Who is sponsoring the NCT06685159 clinical trial?
NCT06685159 is sponsored by Reuven Pizov. The trial plans to enroll 100 participants.